Be part of the knowledge.™

Conference Coverage

ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.

509

LikeLikedUnlike

Episodes 196-210 of 480

Preventive PCI versus optimal medical therapy only for vulnerable plaques
ACC Action Center
Preventive PCI versus optimal medical therapy only for vulnerable plaques
- Marc Bonaca, MD
  Peer
Uncovering a Potential Biomarker for Myasthenia Gravis
NeuroFrontiers
Uncovering a Potential Biomarker for Myasthenia Gravis
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
NeuroFrontiers
Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum
- Eliza C. Miller, MD
  Peer
Managing Internal Medicine Issues in Hospitalized Neurological Patients
NeuroFrontiers
Managing Internal Medicine Issues in Hospitalized Neurological Patients
- Erick Tarula, MD
  Peer
Recognizing and Addressing Medical Gaslighting in Healthcare
NeuroFrontiers
Recognizing and Addressing Medical Gaslighting in Healthcare
- Michele Longo, MD
  Peer
Promising results for APOC3 ASO in familial chylomicronemia syndrome
ACC Action Center
Promising results for APOC3 ASO in familial chylomicronemia syndrome
- Erik Stroes
  Peer
advertisement
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
ACC Action Center
Increasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
- Alexander J. Blood, MD
  Peer
Self-assessment on statin eligibility without prescription using a web app
ACC Action Center
Self-assessment on statin eligibility without prescription using a web app
- Steven Nissen, MD
  Peer
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action Center
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
- Daniel Gaudet, MD, PhD
  Peer
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action Center
Stopping aspirin after 1 month DAPT in ACS patients after stenting
- Gregg Stone, MD
  Peer
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
ACC Action Center
Head-to-head comparison of two TAVR devices in patients with aortic stenosis and small aortic annuli
- Howard C. Herrmann, MD
  Peer
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
ACC Action Center
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
- Brian Bergmark, MD
  Peer
advertisement
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
ACC Action Center
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
- Michael Gibson, MD
  Peer
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
ACC Action Center
Early aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
- Michael Koren, MD
  Peer
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action Center
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
- Javed Butler, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended